Analgesics may be employed for major procedures and postoperative pain, although use of analgesics for minor procedures is less frequent because of concerns about adverse events or toxicity. 1° Various nonpharmacologic methods have been used to decrease pain in infants, including nonnutritive sucking, containment, positioning, and vestibular activity. 1° The most extensively studied nonpharmacologic intervention to decrease pain during procedures in infants is the administration of oral sucrose. 11 Sucrose administered orally before painful procedures has shown a decrease in the following:
• Duration of crying • Facial action associated with pain * Heart rate • Composite pain scores ~° The pain relief elicited by sucrose solutions is thought to be biphasic, with an immediate preabsorptive calming effect, followed by the activation of endogenous opioids. This second mechanism, involving the release of endorphins that decrease pain in infants, is supported by animal studies that have shown that the analgesic effects of sucrose can be blocked by administering an opioid antagonist. .2 In addition, Blass and Ciaramitaro showed that infants born to methadone-dependent mothers were unresponsive to the analgesic properties of sucrose. 13 The Cochrane Collaboration review of sucrose use in neonates undergoing painful procedures concludes that, although there was a reduction in physiologic or behavioral indicators of stress and pain in neonates who received sucrose before painful procedures, there was inconsistency in the optimal dosing that was effective. They also identified a lack of evidence to evaluate safety concerns. 11
The International Evidence-Based Group for Neonatal Pain Consensus Statement includes sucrose as one of several suggested pain management approaches for numerous types of procedures performed on neonates. 4 Administering sucrose to infants requiring painful procedures would seem a relatively simple and low-cost nonpharmacologic method of decreasing pain, although many questions remain regarding safety, dosing, repeated applications, and appropriate uses for sucrose at this time. In an effort to evaluate the published evidence the following critically appraised topic (CAT) was developed to examine the efficacy of sucrose as an analgesic in infants undergoing painful procedures.
The CAT format was developed by Sackett et a114 as a method of critically appraising the literature to answer questions that arise daily in clinical practice. An expanded version of the CAT that was developed by Soil and Andruscavage 15 and further modified for use in this column will be used in this critical appraisal of the literature. (2) sucrose and analgesia. Limits: (Newborn),
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THE STUDY APPRAISED:
The efficacy of sucrose for relieving procedural pain in neonates--a systematic review and meta-analysis l
RATIONALE:
A review of randomized controlled trials (RCTs) revealed several studies, some with a small sample size, as well as a wide range of dosing protocols, administration regimens, measured outcomes, and procedures used as painful stimuli. The selected meta-analysis combined data from 5 RCTs with similar study characteristics, after rating each study for quality, resulting in a summary of results for 271 neonates.
THE EVIDENCE: Methods:
RCTs obtained by literature search (1966 to 1996) were assessed for the quality of their methodology. Data from all RCTs where preterm and term infants received a venipuncture or heelstick were reviewed for efficacy of various sucrose doses (0.18 g, 0.24 g, 0.48 g or 0.5 g, 1.0 g) versus a placebo (water) in blunting pain. The primary outcome was the proportion of crying time during a 3-minute period after the painfu[ stimulus.
Results:
Thirteen RCTs were identified, with 8 being rejected as data were inappropriate, nonextractable, or the primary outcome of interest was not measured, z-9 The remaining 5 studies provided data for 271 neonates (4 with term infants and one with relatively healthy preterm infants 29 to 36 weeks gestational age) undergoing heelstick or venipuncture.l°'14 The proportion of crying time did not differ between the 0. l 8 g dose of sucrose and water (P > 0.05), but was significantly lower in the other sucrose groups versus water groups (0.24 g [P --0.01], 0.48 or 0.5 g [P < 0.001], and 1.0 g [0.001]). Differences were not found in proportion of crying time between preterm and term neonates. Although sucrose administration in some of these studies also was associated with decreased heart rate, facial actions, and motor activity immediately after the painful stimulus, these outcomes were not consistently measured in all of the studies reviewed.
Conclusions:
Sucrose reduced the proportion of crying time in both term and relatively healthy preterm neonates after painful stimuli. The 0.18 g dose was found to be ineffective. Doses of 0.24 g and greater were found to be effective, with no added benefit reported for the 0.5 g and 1.0 g doses (P = 0.074 and 0.225, respectively). 
OTHER RELATED STUDIES:
-ose-induced anagesia in human newborns. L~pertise with the best available clinical research.
The CAT format provides a method of systematically appraising the literature to answer questions that arise in our practice. With a multitude of studies related to sucrose as analgesia for neonates, it is difficult for clinicians to determine the best practice for their patients. This CAT was used to review a meta-analysis of sucrose research in an attempt to collate important findings in several studies that used a variety of dosing regimens and outcome measures. By developing this CAT, results of several studies were translated into meaningful bottom lines for use by the clinician in decision-making. Administering doses of 0.24 g or greater (with no added benefit of doses 0.5 to 1.0 g) of sucrose was found to consistently decrease crying time in neonates undergoing painful procedures making this a promising method of decreasing procedural pain. Although much has been learned through research about sucrose administration in neonates, many other questions remain unanswered (Table 3) . No adverse effects have yet been identified with sucrose use for analgesia. However, there is a lack of sufficient follow-up data for adverse effects in repeated administration of sucrose, especially in preterm infants. None of the studies included in the meta-analysis identified safety issues as primary outcome measures. This leads us to question whether any of these studies had the statistical power to identify potentially catastrophic harmful effects. There is a theoretical risk of oral sucrose being associated with necrotizing enterocolitis (NEC), resulting from local trauma to the gut wall caused by a hypertonic solution. One report of small frequent volumes of 20% sucrose mixed with calcium lactate via nasogastric tube showed a possible association with an increased incidence of NEC. 19 Because of the presence of calcium lactate in the solution, it is unclear whether the sucrose itself contributed to a higher rate of NEC, but the results underscore the need for further research on the effects of repeated applications, especially in preterm infants. Hyperglycemia has been identified as another potential risk, especially for repeated doses in the preterm infant. 4 In addition, there is a concern that sucrose may be harmful to developing teeth. There is some evidence that nonsucrose, sweet-tasting solutions are as efficacious as sucrose in decreasing the crying time after painful procedures, which may offer a solution to that concern, i° More recent studies have shown a reduction in pain indicators with much smaller volumes of 24% sucrose (estimated 0.01 to 0.02 g) in preterm infants when compared with control interventions. I° Although one does not get a true sense of the magnitude of blunting of pain in infants (especially preterm infants) with these smaller doses of sucrose, it is encouraging that a decrease in pain indicators is seen. Smaller doses may result in fewer adverse effects. Until better data related to the safety issues of sucrose administration are available, however, caregivers must proceed with caution in using sucrose as analgesia for painful procedures in neonates, especially preterm infants.
The information in this CAT can be used as a basis for discussion when developing guidelines for neonatal pain prevention and management in your institution. Review Table 3 for practical considerations based on what we do know about sucrose administration and to identify areas needing further discussion before implementing sucrose use in your area of practice.
To learn more about CATs and how you can develop CATs for use in your practice, visit the Advances in Neonatal Care Web site at www. advancesinneonatalcare.org for a CAT tutorial and template. Visit the Centre for Evidence-Based Medicine Web site at http://cebm.jri.ox.ac.uk/for more information on evidence-based medicine and CAT development.
~1
Pain Assessment and Management: NElcV Guiclelinefor Practice, by Marlene Walden, PhD RNC NNP CCNS, is now available. This publication is being supported in part by an unrestricted educational grant from Ross Products Division, Abbott Laboratories, Inc. The guideline discusses and summarizes current pain practices based on best evidence for nursing care of infants. The guideline reviews competencies for assessing and managing pain, identifying the effectiveness of non-pharmacologic and pharmacologic therapies to control or prevent pain, using a collaborative, interdisciplinary approach to pain control, supporting documentation to manage pain, developing policies and procedures to support optimal pain management, and collecting data to monitor the effectiveness of pain management practices. 
